Sponsors / MGTX
MGTX

MeiraGTx, LLC

Company identity has not yet been verified

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
2Trials in this database
6Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late XerostomiaNCT05926765MeiraGTx, LLCPhase 2Active not recruiting2027-06Estimated
Long-term Follow-up of Gene Therapy for Radiation-Induced XerostomiaNCT06544798MeiraGTx, LLCPhase 2Enrolling by invitation2032-02Estimated

Latest recorded trial changes

A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

NCT05926765 · MeiraGTx, LLC

· 4 fields changed

Participant count type

Recorded edit
− Previous value

Estimated

+ Updated value

Actual

Enrollment · participant count

Recorded edit
− Previous value

count: 276; type: ESTIMATED

+ Updated value

count: 290; type: ACTUAL

Primary completion date

Recorded edit
− Previous value

2026-12

+ Updated value

2027-06

Recruitment status

Recorded edit
− Previous value

Recruiting

+ Updated value

Active not recruiting

Check registry source